Locus Biosciences
Precision phage therapeutics.
Morrisville, United States · Founded 2015 · $84.9M raised
- Headquarters
- Morrisville, North Carolina
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- locusbiosciences.com
- Total Funding
- $84.9M
- Last Round
- $35.0M Series BMay 2022
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Locus Biosciences is a clinical-stage precision medicine company developing engineered bacteriophage products that selectively remove disease-causing pathogenic bacteria from the human body. Using a proprietary CRISPR-Cas3 platform combined with high-throughput phage engineering, the company is advancing therapeutics for serious bacterial infections and microbiome indications. Locus conducted the world's first clinical trial of a recombinant CRISPR bacteriophage therapy and is headquartered in Morrisville, North Carolina.
Summary
Locus Biosciences is a Biotech company based in Morrisville, United States, founded in 2015. It has raised $84.9M in total across 4 rounds, most recently a $35.0M Series B round in May 2022. Investors include Artis Ventures (AV), Hercules Capital and Biomedical Advanced Research and Development Authority (BARDA).
Funding History
May 2022
Sign up to see all 5 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/locus-biosciences"><img src="https://indexed.vc/api/badge/company/locus-biosciences" alt="Locus Biosciences on Indexed.vc" width="260" height="76" /></a>